Friedhelm hildebrandt
Company: Harvard Medical School
Job title: Chief of Nephrology
Seminars:
Quantifying Podocyte Targeting by AAV in Mouse Models of Nephrotic Syndrome 12:00 pm
Quantifying podocyte tropism of AAV on a single-cell level Making AAV mediated gene replacement therapy a viable option for many forms of monogenic nephrotic syndrome Improving podocyte tropism for AAV to move the field forwardRead more
day: Conference Day One